Global EGFR-TKI for Advanced NSCLC Market Report By Type (Gefitinib, Erlotinib, Afatinib, Osimertinib), By Application (Combination Therapy, Mono Therapy) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2022-2030
The global demand for EGFR-TKI for Advanced NSCLC Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
EGFR-TKI for Advanced NSCLC refers to as epidermal growth factor receptor- tyrosine kinase inhibitors for advance non-small-cell lung cancer. EGFR-TKI is a substance that blocks or resists the action of enzymes called tyrosine kinases. These enzymes are too active or found at high levels in -small-cell lung cancer, and preventing them help keep cancer cells from growing. It is superior to chemotherapy in terms of progression-free survival (PFS) and objective response rate. Gefitinib, Erlotinib, Afatinib, and Osimertinib are TKIs approved for the treatment of EGFR NSCLC.
Lung cancer is a leading cause of death worldwide, accounting for an estimated 2.09 million cases in 2018. NSCLC is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases. The rising burden of non-small-cell lung cancer is driving the growth of the market. Continuing advances in research and treatment provide opportunities for the market. Companies are are continually looking for new molecules with the enhanced potential to cure NSCLC. The rising R& D activities and growing approval for the TKIs will further amplify market growth. However, researchers are facing many challenges in terms of its effectiveness, which is obstructing new inventions, and hence market growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of EGFR-TKI for Advanced NSCLC.
The entire EGFR-TKI for Advanced NSCLC market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
This section covers regional segmentation which accentuates on current and future demand for EGFR-TKI for Advanced NSCLC market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global EGFR-TKI for Advanced NSCLC Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the EGFR-TKI for Advanced NSCLC market include Henan DaKen Chemical, Capot Chemical Co.,Ltd., Chemwill Asia Co.,Ltd., MSN Labs, Sun Pharma, Amadis Chemical, Chongqing Chemdad Co., Ltd., Mylan, Alchem Pharmtech,Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of EGFR-TKI for Advanced NSCLC Market
2.2. Global EGFR-TKI for Advanced NSCLC Market Snapshot
3 . EGFR-TKI FOR ADVANCED NSCLC – INDUSTRY ANALYSIS
3.2. Market Drivers of EGFR-TKI for Advanced NSCLC Market
3.3. Market Restraints of EGFR-TKI for Advanced NSCLC Market
3.4. Opportunities of EGFR-TKI for Advanced NSCLC Market
3.5. Trends of EGFR-TKI for Advanced NSCLC Market
3.6. Porter's Five Force Analysis of EGFR-TKI for Advanced NSCLC Market
3.7. EGFR-TKI for Advanced NSCLC Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Type
3.7.2 Market Attractive Analysis by Application
3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. EGFR-TKI for Advanced NSCLC Value Chain Analysis
4.2. EGFR-TKI for Advanced NSCLC Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. EGFR-TKI for Advanced NSCLC Raw Material Manufactures List
4.2.3. Price Trend of EGFR-TKI for Advanced NSCLC Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak on EGFR-TKI for Advanced NSCLC Market
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption